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Pulmonary hypertension (PH) may be observed in
many different conditions, including advanced heart
or lung disease [1]. PH is defined as elevation of the
mean pulmonary arterial pressure (mPAP) ≥25 mmHg,
measured by right heart catheterization (RHC). Since
procedure-related risks and costs are not negligible,
RHC is not routinely performed in patients with ad-
vanced lung disease during initial assessment and
follow-up. Echocardiography is commonly used as
screening tool for the presence of PH, but might be
of limited diagnostic value, in particular in patients
with lung disease [2]. Empirical formulas were pro-
posed to calculate the mPAP starting from systolic
pulmonary arterial pressure (sPAP) as assessed by
echocardiography [3, 4]. It has been suggested that
both the Chemla formula (mPAP = sPAP × 0.61 +
2 mmHg) and the Syyed formula (mPAP = sPAP ×
0.65 + 0.55 mmHg) might accurately estimate the
mPAP [5]. The aim of our study was to assess the
accuracy of these echocardiography-based formulas
to estimate the invasively measured mPAP in a co-
hort of patients with advanced lung disease. Estima-
tion of sPAP by echocardiography was performed
according to current recommendation by adding to
the right ventricular/right atrial pressure gradient
(based on Doppler-measured tricuspid regurgitation
velocity) the estimated right atrial pressure (based on
inferior vena cava diameter and collapsibility). A total
of 96 consecutive patients undergoing lung transplant
evaluation between 03/2000 and 10/2015 were in-
cluded. Data from RHC and echocardiography per-
formed the same day were available for the whole
cohort.
Spearman’s rank-order correlation was run to as-
sess the relationship between RHC-measured mPAP
and calculated mPAP. There was a strong positive
correlation between both RHC-mPAP and Chemla-
mPAP (rs = 0.909, p < 0.001; Fig. 1a) and between
RHC-mPAP and Syyed-mPAP (rs = 0.904, p < 0.001;
Fig. 1b).
Inspection of both diagrams suggests that the cor-
relation between echocardiographic data and invasive
pulmonary hemodynamics is of particular strength in
patients with moderate elevation of pulmonary pres-
sure. Whether echocardiography-based formulas are
of similar accuracy to estimate pulmonary pressure
of PH in patients with severe PH remains unclear.
However, this might be of minor relevance since, as
shown in our cohort, only a minority of patients
with advanced lung disease present with a mPAP
>50 mmHg. In these patients, further invasive as-
sessment of pulmonary hemodynamics may be indi-
cated. For all other patients our data emphasize that
echocardiography is an accurate tool to estimate pul-
monary pressure in patients with advanced lung
disease.
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Fig. 1 Correlation between RHC-measured mPAP and echocardiographic-estimated mPAP using the Chemla formula (a) and the Syyed formula
(b). Values expressed as mmHg
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